drugset
drugset / Trial / NCT00198484

Evaluation of Vitrase as a Spreading Agent

NCT00198484 ↗

Phase 3 Completed 108 enrolled Bausch & Lomb Incorporated
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Vitrase (hyaluronidase for injection) is effective as a spreading agent for other injected drugs prior to ocular surgery

Timeline

Start
2004-10
Primary completion
2004-12
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject HYALURONIDASE (OVINE) Protein / enzyme biologic 150 iu —

Indications

No indication recorded.